Company Encyclopedia
View More
name
Anbio Biotechnology
NNNN.US
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany.
1.813 T
NNNN.USMarket value -Rank by Market Cap -/-

Financial Score

11/11/2025 Update
B
BiotechnologyIndustry
Industry Ranking34/387
Industry medianC
Industry averageD
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE14.83%A
    • Profit Margin28.99%A
    • Gross Margin71.90%A
  • Growth ScoreB
    • Revenue YoY21.95%A
    • Net Profit YoY5.29%C
    • Total Assets YoY19.67%A
    • Net Assets YoY16.01%A
  • Cash ScoreB
    • Cash Flow Margin344.95%C
    • OCF YoY21.95%A
  • Operating ScoreC
    • Turnover0.47C
  • Debt ScoreA
    • Gearing Ratio9.14%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Anbio Biotechnology presented its diagnostic products at WSAVA 2025 in Rio de Janeiro with attendees from 100+ countries.

    Rio de Janeiro hosted the 50th World Small Animal Veterinary Association Congress (WSAVA 2025), where Anbio Biotechnology took part. The event drew participants from over 100 countries, including veterinarians, researchers, and industry professionals.

    Unusual Whales·
    US
    NNNN
    +33.01%
    Unusual Whales·
    US
    NNNN
    +33.01%

    23:41 ET Driving Veterinary Healthcare Forward: Anbio Showcases Diagnostic Portfolio at WSAVA 2025

    Anbio Biotechnology showcased its veterinary diagnostic portfolio at the 50th WSAVA Congress 2025, engaging with global veterinarians and industry representatives. The company presented five product lines, including advanced molecular diagnostics capable of rapid results for infectious diseases. The event highlighted the growing demand for accessible testing technologies in veterinary healthcare and emphasized international collaboration. Anbio plans to continue its outreach at the Wild West Vet Show 2025, furthering its commitment to improving healthcare outcomes through reliable diagnostics.

    prnewswire·
    US
    NNNN
    +33.01%
    prnewswire·
    US
    NNNN
    +33.01%

    White Mountains Insurance, Rumble, Mesoblast And Other Big Stocks Moving Higher On Friday

    U.S. stocks rose on Friday, with the Dow Jones gaining over 350 points. White Mountains Insurance Group's shares surged 9.2% to $1,817.83 after announcing the sale of a controlling interest in its tech-driven homeowners' insurance platform, Bamboo, valued at $1.75 billion. Other notable gainers included Anbio Biotechnology (+69.6%), Lithium Americas (+29.1%), and Rumble Inc. (+14.6%) following a partnership announcement. Mesoblast Limited's shares rose 7.7% after receiving a J-Code for Ryoncil, easing billing processes.

    Benzinga·
    US
    WTM
    +1.22%
    US
    RUM
    -6.40%
    Benzinga·
    US
    WTM
    +1.22%
    US
    RUM
    -6.40%

    Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System | NNNN Stock News

    Anbio Biotechnology has launched a Chikungunya IgM/IgG Rapid Test and the AP-100 Ultra-Fast PCR system to enhance outbreak detection and response. The rapid test provides quick diagnostics for Chikungunya fever, crucial for differentiating from other infections like Dengue and Zika. The AP-100 delivers lab-grade PCR results in just 15 minutes, streamlining workflows for both centralized and point-of-care testing. Anbio aims to improve global health preparedness with these innovations, expanding its diagnostic capabilities to include tests for TB and HPV.

    StockTitan·
    US
    NNNN
    +33.01%
    StockTitan·
    US
    NNNN
    +33.01%

    13 Best German Stocks to Invest in Now

    This article discusses the 13 best German stocks to invest in, highlighting the recent decline in European shares and the performance of Germany's DAX index, which has gained 19.48% year-to-date. The German cabinet approved a draft budget for 2025, focusing on economic growth and defense spending. The article also features Anbio Biotechnology and Evotec SE, detailing their recent developments and investor interest. Anbio's IPO saw a 600% surge, while Evotec received a Buy rating from Warburg Research, indicating strong investor sentiment.

    insidermonkey·
    US
    EVO
    -0.67%
    US
    NNNN
    +33.01%
    insidermonkey·
    US
    EVO
    -0.67%
    US
    NNNN
    +33.01%